Phase III Trial Comparing AC-T with AC-TH and with TCHin the Adjuvant Treatment of
HER2 positive Early Breast Cancer Patients: Second Interim Efficacy AnalysisSlamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Pawlicki M, Chan A, Smylie M, Liu M, Falkson C, Pinter T, Fornander T, Shiftan T, Valero V, Von Minckwitz G, Mackey J, Tabah-Fisch I, Buyse M, Lindsay MA, Riva A, Bee V, Pegram M, Press M, Crown J, on behalf of the BCIRG 006 Investigators.
Study sponsored by Sanofi-Aventis Support fro ...


雷达卡


京公网安备 11010802022788号







